Tailwind for Prevenar 13? Vaccine Panel Members Up for Its Use in High-Risk Elderly

NIID Director General Takaji Wakita Pfizer’s pneumococcal vaccine Prevenar 13 might not make it into the Japanese public immunization program for the entire elderly population, but it could for a certain high-risk subset, with its national health reimbursement for these...read more